Professor Adrian P. Banning, MD, FRCP, FESC graduated from St Georges in London before moving to Cardiff as an SPR where he obtained a BHF Junior fellowship and an MD. Moved to Oxford in 1995 and appointed Consultant Cardiologist in 1999. He was at the forefront of the initiation of day case coronary intervention for elective patients and day case transfer for treatment for ACS patients. Subsequently prominent in the early development of drug eluting stents particularly the Taxus series of trials and in the pivotal stents vs surgery trials including Syntax, Excel and co CI of Syntax 2. He has a specialist interest in treatment and imaging for left main coronary disease and was co -chief investigator in the recent OPTIMAL trial. Live case operator and principal host operator for a variety of international case meeting including PCR TCTAP and TCT. Recent ex -President of the British Cardiac Intervention Society. Author of >550 PUBMED cited papers with an ‘h’ index >90. His academic interest in myocardial injury during revascularisation and optimisation of myocardial perfusion in STEMI resulted in the award of the title Professor of Interventional Cardiology by Oxford University.

Sarah Fairley trained in Belfast, Northern Ireland, and has a PhD from Queens University Belfast. Sarah currently works as an interventional and obstetric cardiologist at Wellington Hospital, is the current chair of the NZ Interventional Working Group and Treasurer of the NZ branch of CSANZ. Sarah has interests in complex PCI / intracoronary imaging / high-risk cardiac pregnancies / SCAD / RHD / equitable healthcare delivery.

Dr Sara Hungerford (MBBS, FRACP, FCSANZ, FACC, PhD) is a cardiologist specialising in structural heart disease imaging and a National Heart Foundation Senior Postdoctoral Fellow. She recently completed international fellowships at Tufts Medical Center in Boston, USA, and the Royal Brompton Hospital in London, UK. Her research focuses on advanced cardiac imaging techniques to improve understanding and prediction of haemodynamic responses to transcatheter valve interventions.

David Muller is Professor of Medicine at the University of New South Wales, Director of Interventional Cardiology Services at St Vincent’s Hospital, Sydney, and a faculty member of the Victor Chang Cardiac Research Institute. After graduating from the University of Melbourne, he completed his Advanced Training in Cardiology in Melbourne and Interventional Cardiology Fellowship at the University of Michigan Medical Centre. His current major research interests include transcatheter therapies for structural heart disease, the physiological and haemodynamic responses to transcatheter valve interventions, and optimizing the outcomes of complex coronary interventions. He has published widely (>500 peer reviewed papers, abstracts and book chapters) and is a regular speaker at international Cardiology meetings. He has held leadership roles in multiple international device trials, including first-in-human studies, and has been a member of numerous state and federal government Advisory Committees.